-
During the past few months, IQWiG has made several decisions public for recently reviewed drugs. For the first time, a body of evidence exists which can shed some light upon how restrictive and how timely access will be under the new AMNOG legislation regime in Germany. learn more
AMNOG | Cyrus Chowdhury | market access | global market access | IQWiG | AMNOG legislation | G-BA’s | brand managers | Germany | Germant market access
-
Recently a number of high profile pharmaceutical companies have announced significant job cuts and many pharmaceutical professionals feel uncertain about their job stability in 2012. In a recent global study by Pharma IQ entitled “The Big Pharma Recession Survey 2011”, nearly half of the survey participants 44.4 percent said that they were worried that their role might be made redundant in the next 12 months. learn more
pharma recession | pharmaceutical recession | pharma jobs | pharmaceutical jobs | pharma job cuts | job cuts | redundancy | global economic crisis | economic crisis | double dip recession | pharmaceutical outsourcing | offshoring | development | R&D costs | pharma sales
-
This paper explores some of the major challenges facing the pharmaceutical industry today. Delivering shareholder/stakeholder value, low growth business environment, R&D productivity and rising risks and loss of trust. learn more
pharmaceutical industry | future pharma | R&D productivity | risk |
-
Given the complexity and uncertainty of the biosimilar regulatory landscape in the developed markets -particularly the USA -as well as the high cost of clinical development in these markets, many potential biosimilar manufacturers are looking to the emerging markets (EM) as a high commercial opportunity. learn more
biosimilars | biosimilars market | biologic sales | patents | patent protection | monoclonal antibodies | mAbs | biosimilar regulatory landscape | biosimilar manufacturers | emerging markets | Cyrus Chowdhury | Monica Martin de Bustamante | Rachel Beckerman
-
Pharma marketers now face the challenge of communicating consistently, globally and across multiple channels in ways never before seen. Robust campaigns are required. Changes in infrastructure and internal processes are crucial to success. This whitepaper explores the new Pharma marketing landscape, the challenges, communication alternatives and what Pharma marketers and their agencies require to compete more efficiently and effectively. It introduces Digital Asset Management (DAM) a powerful tool that drives compelling results by enabling access, collaboration, production and distribution of marketing materials at any stage of a campaign’s lifecycle and empowers Pharma marketers to perform brand management more effectively locally, regionally and globally. learn more
pharma marketing | pharmaceutical marketing | pharma marketer | DAM | brand management | Digital Asset Management | North Plains
-
International reference pricing has grown from an evolving cost-containment philosophy in Western Europe, to a trusted policy tool readily adopted by emerging markets around the world. learn more
EU accession reference pricing | reference pricing | market access | EU accession | pharmaceutical budgetary controls | accession markets | European ‘single-market’ | Cyrus Chowdhury | pharmaceutical pricing | pricing negotiation | future EU accession markets
-
The following interviews are part of a Five-Part Series on Marketing Excellence, which draws on landmark IMS research on more than 3,000 new product launches and analysis of 50 in-line brands spanning 10 chronic retail markets. learn more
marketing excellence | pharma marketing excellence | brand excellence | dynamic market | product launch | brand planning | brand growth
-
Global Pharmaceutical Distribution 2012
Venue to be Confirmed, Amsterdam, The Netherlands
September 18- 19, 2012 -
Cool Chain Logistics 2013
Congress Center Basel, Basel, Switzerland
January 28- 30, 2013 -
Information Governance & eDiscovery for Pharma, Biotech and Medical Devices
London, UK
June 26- 28, 2012 -
Cold Chain Global Forum 2012
Chicago, IL
September 24- 28, 2012
|
|
|
|
Subscribe by Email
|
Reach Pharma professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Learn More >> Join today and interact with a vibrant network of pharma professionals, keeping up to date with the pharma industry by accessing our wealth of Pharma articles, videos, online seminars, live conferences and more. Sign Up Today! |
| Pharma IQ, a division of IQPC 2012 All rights reserved. Use of this site constitutes acceptance of our User Agreement and Privacy Policy. Careers With IQPC | Contact Us | Unsubscribe to Bizo | About Us |
|
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!